Clinical trial
Optimally Sequential Treatment of Integrated Chinese and Western Medicine for Psoriasis: a Multicenter Randomized Controlled Trial
NCT03941431 is registered in ClinicalTrials.gov with Shanghai Yueyang Integrated Medicine Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimally Sequential Treatment of Integrated Chinese and Western Medicine for Psoriasis: a Multicenter Randomized Controlled Trial
- Lead sponsor
- Shanghai Yueyang Integrated Medicine Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 1, 2019
- Completion date
- December 31, 2021
- Enrollment
- 378 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
plaque psoriasis